Benzinga | Nov 3, 2020 06:44AM EST

HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Lowers Price Target to $28

HC Wainwright & Co. maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and lowers the price target from $34 to $28.